Literature DB >> 16211601

Eye-hand coordination in essential tremor.

Peter Trillenberg1, Julia Führer, Andreas Sprenger, Ania Hagenow, Detlef Kömpf, Roland Wenzelburger, Günther Deuschl, Wolfgang Heide, Christoph Helmchen.   

Abstract

Patients with essential tremor (ET) or with cerebellar lesions have in common oculomotor abnormalities, with the exception of saccadic eye movements, which do not seem to be involved in ET. Since grasping is prolonged in ET and might be related to saccadic dysmetria, we tested whether simultaneous hand pointing could unmask it. Twelve ET patients and 14 controls performed saccades with and without simultaneous pointing movements to the same targets, and with and without a gap between the disappearance of the fixation point and the appearance of the target. Eye movements were recorded with the magnetic search-coil method, hand movements with an ultrasound-emitting probe. ET patients did not have saccadic dysmetria, and contrary to normal subjects their saccadic latency did not decrease during combined eye-hand movements compared with saccades performed in isolation. Hand movements had a longer duration in ET patients, with decreased peak acceleration, an increased latency of the peak velocity, and peak deceleration. In conclusion, this first study on eye-hand coordination in ET revealed abnormal kinematic changes in the early phase of pointing movements. These changes might be related to cerebellar disease but they are independent of the intention tremor component and saccade performance. (c) 2005 Movement Disorder Society.

Entities:  

Mesh:

Year:  2006        PMID: 16211601     DOI: 10.1002/mds.20729

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  29 in total

1.  High width variability during spiral drawing: further evidence of cerebellar dysfunction in essential tremor.

Authors:  Elan D Louis; Arthur Gillman; Sarah Boschung; Christopher W Hess; Qiping Yu; Seth L Pullman
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

Review 2.  Association between essential tremor and other neurodegenerative diseases: what is the epidemiological evidence?

Authors:  Hiral LaRoia; Elan D Louis
Journal:  Neuroepidemiology       Date:  2011-07-13       Impact factor: 3.282

3.  Essential tremor: is it a neurodegenerative disease? No.

Authors:  Monica M Kurtis
Journal:  J Neural Transm (Vienna)       Date:  2012-08-17       Impact factor: 3.575

4.  Essential tremor is a neurodegenerative disease.

Authors:  Ubaldo Bonuccelli
Journal:  J Neural Transm (Vienna)       Date:  2012-08-23       Impact factor: 3.575

Review 5.  Milestones in clinical neurophysiology.

Authors:  Mark Hallett; John Rothwell
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

6.  Consensus paper: Decoding the Contributions of the Cerebellum as a Time Machine. From Neurons to Clinical Applications.

Authors:  Martin Bareš; Richard Apps; Laura Avanzino; Assaf Breska; Egidio D'Angelo; Pavel Filip; Marcus Gerwig; Richard B Ivry; Charlotte L Lawrenson; Elan D Louis; Nicholas A Lusk; Mario Manto; Warren H Meck; Hiroshi Mitoma; Elijah A Petter
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847

Review 7.  Essential Tremor Within the Broader Context of Other Forms of Cerebellar Degeneration.

Authors:  Elan D Louis; Phyllis L Faust
Journal:  Cerebellum       Date:  2020-12       Impact factor: 3.847

Review 8.  Essential tremor: from bedside to bench and back to bedside.

Authors:  Elan D Louis
Journal:  Curr Opin Neurol       Date:  2014-08       Impact factor: 5.710

Review 9.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

Review 10.  From neurons to neuron neighborhoods: the rewiring of the cerebellar cortex in essential tremor.

Authors:  Elan D Louis
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.